Understanding Communication Barriers in Acute Care: A Mixed-Methods Needs Assessment Among Healthcare Providers Caring for Non-Verbal Patients With Spinal Cord Injury and Tracheostomy in the ICU

August 27, 2026 updated by: Jason Chui, University of British Columbia

Communication impairment is common among critically ill patients who are mechanically ventilated, have tracheostomies, or have neurological injuries such as spinal cord injury. In acute care settings, inability to communicate contributes to patient distress, impairs symptom assessment, and may delay care. Although a range of communication supports exist, many are difficult to use in patients with severe weakness, limited endurance, or fluctuating cognition. More advanced assistive communication systems, including eye-tracking and brain-computer interface platforms, have shown promise in chronic neurological populations but have not been well adapted to the practical realities of acute care.

This study will use a sequential exploratory mixed-methods design to better understand communication barriers in acute care from the perspective of frontline healthcare providers. In the qualitative phase, semi-structured interviews will be conducted with nurses and speech-language pathologists working with patients who have spinal cord injury, tracheostomy, or other causes of impaired verbal communication in ICU and related acute care settings. Findings from these interviews will inform development of a structured survey to be distributed to a broader group of nurses and speech-language pathologists. Qualitative and quantitative findings will then be integrated to identify priority communication needs, limitations of current strategies, and practical requirements for future assistive communication tools. Findings will inform development of clinically relevant communication solutions for acute care environments.

Study Overview

Status

Not yet recruiting

Detailed Description

This study will employ a two-stage sequential exploratory mixed-methods design. In the first stage, semi-structured interviews (N=10-15) and, where feasible, focus groups will be conducted with ICU clinicians and rehabilitation staff to identify communication barriers and priority use cases for assistive communication in nonverbal patients. Themes emerging from qualitative analysis will inform the development of a structured survey, which will be administered to a broader cohort of clinical staff (N=80-100) to quantify the prevalence and relative importance of identified communication gaps. Findings from the qualitative and quantitative phases will be integrated to generate a clinical requirements framework to inform the future development of assistive communication tools for acute care settings.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jason Chui, MBChB, FRCPC
  • Phone Number: 66378 604-875-4111
  • Email: jason.chui@ubc.ca

Study Contact Backup

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Vancouver General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Care givers to the non-verbal patients with communication barrier

Description

Inclusion Criteria:

  • be a healthcare provider such as physicians, registered nurses, speech-language pathologists, occupational therapists, or physiotherapists;
  • work in ICU, spine, neurosurgical, or related acute care inpatient settings;
  • have experience caring for patients with impaired verbal communication, including patients with tracheostomy, mechanical ventilation, or spinal cord injury; and
  • be able to provide informed consent. A small subset of family caregivers may also be included if they have direct experience supporting communication for patients with impaired verbal communication in these settings.

Exclusion Criteria:

  • Individuals not directly involved in the care of patients with impaired verbal communication in the relevant clinical settings
  • Trainees who are not yet independently practicing, unless they are participating in an independent clinical role
  • Family caregivers without direct experience supporting communication needs in the acute care setting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High-priority Communication Needs in Acute Care
Time Frame: At completion of the 3-5-minute survey on Day 1
Communication needs identified as high priority by healthcare providers based on their ratings of the importance and frequency of communication needs experienced by patients with impaired verbal communication in acute care settings. The survey will also assess which communication functions healthcare providers consider most important for inclusion in future assistive communication interfaces.
At completion of the 3-5-minute survey on Day 1
Priority of Communication Needs in Acute Care
Time Frame: Stage 1 interviews and Stage 2 survey; approximately Months 3-4
Healthcare providers' ratings of the importance and frequency of communication needs experienced by patients with impaired verbal communication in acute care settings. Priority communication needs will be identified through thematic analysis of interviews and quantified in the Stage 2 survey using importance and frequency ratings.
Stage 1 interviews and Stage 2 survey; approximately Months 3-4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Current Communication Strategies and Perceived Limitations
Time Frame: Stage 1 interviews and Stage 2 survey; approximately Months 3-4
Identification and characterization of communication strategies currently used by healthcare providers, including low-technology and augmentative and alternative communication approaches, and perceived limitations or barriers associated with their use. Findings will be derived from qualitative interviews and summarized quantitatively in the survey where applicable.
Stage 1 interviews and Stage 2 survey; approximately Months 3-4
Priority Communication Functions for Bedside Use
Time Frame: Stage 2 survey; approximately Month 4
Healthcare providers' prioritization of communication functions considered most appropriate for a simplified bedside assistive communication interface. Participants will select a limited number of communication functions from those identified during the qualitative phase.
Stage 2 survey; approximately Month 4
Workflow and Implementation Feasibility Requirements
Time Frame: Stage 1 interviews and Stage 2 survey; approximately Months 3-4
Healthcare providers' perceptions of practical requirements for implementing assistive communication tools in acute care, including acceptable setup time, training requirements, workflow integration, and environmental or clinical barriers.
Stage 1 interviews and Stage 2 survey; approximately Months 3-4

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Communication System Functional Requirements
Time Frame: Stage 1 interviews and Stage 2 survey; approximately Months 3-4
Identification of functional and interface requirements for future assistive communication systems, including required communication tasks, presentation/interface considerations, contextual information, and usability requirements. Requirements will be identified through thematic analysis and prioritized using survey findings.
Stage 1 interviews and Stage 2 survey; approximately Months 3-4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

July 28, 2026

First Submitted That Met QC Criteria

August 27, 2026

First Posted (Actual)

August 31, 2026

Study Record Updates

Last Update Posted (Actual)

August 31, 2026

Last Update Submitted That Met QC Criteria

August 27, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This study involves survey data only. Additional approval is required to share the data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe